RecruitingNCT06040567

Polyneuropathy, Impairments and Physical Activity - The PolyImPAct Study

Sponsor

Rigshospitalet, Denmark

Enrollment

520 participants

Start Date

Sep 23, 2023

Study Type

OBSERVATIONAL

Conditions

Multifocal motor neuropathy Polyneuropathies POEMS Syndrome Diabetic Polyneuropathy Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)Charcot-Marie-Tooth Vasculitic Neuropathy hATTR Amyloidosis Idiopathic Neuropathy

Summary

The project aims to investigate the validity, and reliability of outcome measures of muscle strength, functioning (gait, balance, and fine motor skills), physical activity, and patient-reported outcome measures of functioning (gait, balance, and fine motor skills), and daily living among patients with polyneuropathy. Further, the project aims to compare physical activity and patient-reported outcome measures of functioning (gait, balance, and fine motor skills), and daily living among patients with polyneuropathy with physical activity and patient-reported outcome measures of functioning (gait, balance, and fine motor skills) and daily living in healthy adults.

Eligibility

Min Age: 18 YearsMax Age: 100 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Healthy controls and Validity and reliability of outcome measures in polyneuropathy for people with charcot-marie-tooth, chronic inflammatory demyelinating polyneuropathy (cidp), and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 100 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERValidity and reliability of outcome measures in polyneuropathy

Patients will be tested, answer patient reported outcome measures, and wear accelerometer at baseline after 2-4 weeks and after 1-2 years.

OTHERHealthy controls

Healthy controls will be tested, answer patient reported outcome measures, and wear accelerometer at baseline visit. There is no follow-up in the healthy control group.